関連する実験動画
Updated: Jun 30, 2026

03:22
Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
[DGPおよびÖGPコングレス2025:インターベンション肺科学のハイライト]
Eldridge Limen1,2, Georg Murauer3, Michael Meilinger4
1Abteilung für Pneumologie und Beatmungsmedizin, Thoraxklinik am Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
Pneumologie (Stuttgart, Germany)
|February 24, 2026
まとめ
ドイツおよびオーストリア呼吸器病学会議からのインターベンション肺科学のハイライトは、末梢肺結節に対する診断および治療用気管支鏡検査の革新と、内視鏡的肺容量減少の新たな進歩を紹介しています。
科学分野:
- 肺科学
- インターベンション肺科学
- 医学会議
背景:
- ドイツ呼吸器病学会(DGP)およびオーストリア呼吸器病学会(ÖGP)の会議は、呼吸器医学の進歩を発表するための重要なイベントです。
- インターベンション肺科学は、肺内での低侵襲診断および治療手技に焦点を当てています。
研究 の 目的:
- 2025年3月のDGPおよび2025年10月のÖGP会議で発表されたインターベンション肺科学における主要な発見と新たなトレンドを要約すること。
- 気管支鏡検査および内視鏡的肺容量減少技術の革新を強調すること。
主な方法:
- 2025年のドイツ呼吸器病学会(DGP)およびオーストリア呼吸器病学会(ÖGP)会議からの発表および研究のレビュー。
- 末梢肺結節に対する診断および治療用気管支鏡検査、および内視鏡的肺容量減少を含む主要なテーマの特定。
主要な成果:
- 多数の前向きおよび後ろ向き研究が発表され、貴重な洞察が提供されました。
- 末梢肺結節に対する診断および治療用気管支鏡検査における主要な革新が議論されました。
- 内視鏡的肺容量減少技術の新たな進歩が重要な焦点となりました。
結論:
- 会議は、インターベンション肺科学の現状と将来の方向性についての包括的な概要を提供しました。
- 気管支鏡検査および肺容量減少戦略の進歩は急速に進化しています。
- これらの革新は、さまざまな肺疾患の患者ケアを向上させることが期待されます。
関連する概念動画
Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...

